Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volume 22, 2020 Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2019031168
pages 645-656

The Inhibitory Properties of Ethanol Extracts of Some Culinary-Medicinal Mushrooms on the Secretion of Interleukin-8 and Vascular Endothelial Growth Factor by PC3 Cancer Cells

Christine French
Oklahoma State University, Department of Nutritional Sciences, Stillwater, OK 74078, USA
Chandra LC
Oklahoma State University, Department of Nutritional Sciences, Stillwater, OK 74078, USA
Stephen L . Clarke
Departments of Nutrition The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104; Oklahoma State University, Department of Nutritional Sciences, Stillwater, OK 74078, USA
Edralin A. Lucas
Oklahoma State University, Department of Nutritional Sciences, Stillwater, OK 74078, USA
Brenda J. Smith
Oklahoma State University, Department of Nutritional Sciences, Stillwater, OK 74078, USA
Stanley Lightfoot
Oklahoma University Health Sciences Center, VA Hospital, Oklahoma City, OK 73104, USA
Solo R. Kuvibidila
Oklahoma State University, Department of Nutritional Sciences, Stillwater, OK 74078, USA; The Research Institute of Children's Hospital, Louisiana State University Health Sciences Center, Department of Pediatrics, Division of Research, 200 Henry Clay, New Orleans, LA 70118, USA


Interleukin (IL)-8, a cytokine produced by immune and non-immune cells, induces angiogenesis via increased vascular endothelial growth factor (VEGF) secretion; both cytokines promote tumor growth. IL-8 and VEGF plasma levels correlate with prostate cancer severity, suggesting that therapeutic options aimed at their downregulation may modulate tumor growth. Available data suggest that Agaricus bisporus (white button mushroom [WBM]) extracts inhibit cancer cell proliferation through aromatase inhibition. However, the extent to which they affect IL-8 and VEGF remains to be elucidated. The aims of this study were to (1) investigate the antiproliferative properties of WBM, brown A. bisporus (portabella), and Lentinus edodes (shiitake mushroom) on PC3 cancer cells; (2) demonstrate that these properties are exerted through the regulation of both IL-8 and VEGF; and (3) determine the role of NFκB activation in the antiproliferative process of mushroom extracts. Cytokine secretion in the supernatant, NFκB activity, and cell proliferation were measured in PC3 cells incubated with 0−100 µg/mL of ethanol extracts of mushrooms. Mushroom extracts decreased IL-8 secretion and cell proliferation (P < .05), and also tended to decrease VEGF (P < .09). Decreased cell proliferation did not appear to result from cell death because trypan blue exclusion tests showed comparable cell viability among cultures. Mushroom extracts also decreased nuclear and total NFκB activity, and the ratio of nuclear to cytoplasmic activity (P < .05) suggesting altered translocation from the cytoplasm to the nucleus. Our data suggest that the three types of studied mushrooms may modulate tumor growth through inhibition of IL-8, VEGF, and NFκB pathways.


  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.

  2. Siegel RL, Kimberly D. Miller KD Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.

  3. Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, Miralbell R, Zanetti R. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer. 2008;123:421-29.

  4. Freedland SJ. Screening, risk assessment, and the approach to therapy in patients with prostate cancer. Cancer. 2011;117(6):1123-35.

  5. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;5:578-83.

  6. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281(17):1591-97.

  7. Aragon-Ching JB, Madan RA, Dahut WL. Angiogenesis inhibition in prostate cancer: current uses and future promises. J Oncol. 2010; Article ID 361836; doi:1155/2010/361836.

  8. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401-10.

  9. Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, Berry D, Steward W, Dennison A. The effect of omega-3 fatty acids on tumour angiogenesis and their therapeutic potential. Eur J Cancer. 2009;45:2077-86.

  10. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemikines. Adv Immunol. 1994;55:97-109.

  11. Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res. 2007;67(14):6854-62.

  12. Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML, Lee YC, Yang PC. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small lung cancer. Clin Cancer Res. 2003;9:729-37.

  13. Reiland J, Furcht LT, McCarthy JB. CXC-Chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate. 1999;41:78-88.

  14. Singh RK, Lokeshwar BL. Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs. Mol Cancer. 2009;8:57; doi:1186/1476-4598- 8-57.

  15. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735-41.

  16. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-76.

  17. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. During angiogenesis, vascular endothelial growth factor regulates natural killer cell adhesion to tumor endothelium. Nature Med. 1996;2:992-97.

  18. Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 2001;19(1):72-80.

  19. Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamiton AS, Gillliland FD, Eley JW, Stephenson RA, Hoffman MR. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001;19(17):3750-57.

  20. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME. The immunobiology of mushrooms. Exp Biol Med. 2008;233(3):259-76.

  21. Lull C, Wichers HJ, Savelkoul HF. Antiinflammatory and immunomodulating properties of fungal metabolites. Mediat Inflam. 2005;2:63-80.

  22. Zaidman BZ, Yassin M, Mahajna J, Wasser SP Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. 2005;67:453-58.

  23. Adams LS, Phung S, Wu X, Ki L, Chen S. White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice. Nutr Cancer. 2008;60(6):744-46.

  24. Wasser PS. Medicinal mushroom science: history, current status, future trends and unsolved problems. Int J Med Mushrooms. 2010;12(1):1-16. doi:10.1615/IntJMedMushr.vol12.i1.10.

  25. Wasser SP. Medicinal mushrooms in human clinical studies. Part I: anticancer, oncoimmunological, and immunomodulatory activities: a review. Int J Med Mushrooms. 2017;19(4):279-317.

  26. Rubel R, Santa HSD, Dos Santos LF, Fernades LC, Figueiredo BC, Soccol CR. Immunomodulatory and antitumoral properties of Ganoderma lucudum and Agaricus brasiliensis (Agaricomycetes) medicinal mushrooms. Int J Med Mushrooms. 2018;20(4):393-403.

  27. Ikekawa T. Cancer risk reduction by intake of mushrooms and clinical on EEM (extracts of edible mushrooms). Int J Med Mushrooms. 2005;7(3):347. doi:10.1615/ Int J Med Mushrooms. v7.i3.110; pp347.

  28. Chen S, Phung S, Kwok S, Ye J, Hur G, Oh S, Smith D, Yuan YC, Karisberg K, Lui K. Chemopreventive properties of mushrooms against breast and prostate cancer. Int J Med Mushrooms. 2005;7(3):342-343. doi:1615/ Int J Med Mushrooms. v7.i3.71; pp. 342-43.

  29. Kim SJ, Uehara H, Karashima T, McCarty M, Shih N, Fidler IJ. Expression of interleukin-8 correlates with angiogenesis, tu- morigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia. 2001;3:33-42.

  30. Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, Resnick MI, Gupta R. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia. 2004;6:390-400.

  31. Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Cher HI, Gerald WL. NF-kB regulates androgen receptor expression and prostate cancer growth. Am J Pathol. 2009;175:489-99.

  32. Kuvibidila S, Korlagunta K. Extracts of culinary-medicinal mushrooms increase intracellular a-defensins 1-3 concentration in HL60 cells. Int J Med Mushrooms. 2010;12:33-42.

  33. Yap AT, Ng ML. An improved method for the isolation of lentinan from shiitake mushroom (Lentinus edodes). Int J Med Mushrooms. 2001;3:9-19.

  34. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S , Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP. Interleukin-8 expression regulates tumorgenicity and metastases in androge-independent prostate cancer. Clin Cancer Res. 2000;6:2104-19.

  35. Rega G, Kaun C, Demyanets S, Pfaffenberger S, Rychli K,Hohensinner PJ, Kastl SP Speidl WS, Weiss TW, Breuss JM, Furnkranz A, Uhrin P, Zaujec J, Zilberfarb V, Frey M, Roehle R, Maurer G, Huber K, Wojta J. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin M in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol. 2007;27:1587-95.

  36. Maxwell PJ, Gallagher R, Seaton A, Wilson C, Scullin P, Pettigrew J, Stratford, IJ, Williams KJ, Johnston PG, Waugh DJJ. HIF-1 and NF-Kb-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene. 2007;26:7333-45. doi:10.1038/sj.onc.1210536.

  37. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwall BB. NF-kB addiction and its role in cancer: 'one size does not fit all'. Oncogene. 2011;30(14):1615-30. doi:10.1038/onc.2010.566.

  38. Park MH, Hong JT. Roles of NF-kB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 2016;5(15):1-13. doi:10.3390/cells5020015.

Articles with similar content:

Turmeric Bioprocessed with Mycelia from the Shiitake Culinary-Medicinal Mushroom Lentinus edodes (Agaricomycetes) Protects Mice Against Salmonellosis
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 4
Sung Phil Kim, Seok Hyun Nam, Mendel Friedman, Sang Jong Lee
Diallyl Disulfide Induces Caspase-Dependent Apoptosis via Mitochondria-Mediated Intrinsic Pathway in B16F-10 Melanoma Cells by Up-Regulating P53, Caspase-3 and Down-Regulating Pro-Inflammatory Cytokines and Nuclear Factor- κβ-Mediated Bcl-2 Activation
Journal of Environmental Pathology, Toxicology and Oncology, Vol.29, 2010, issue 2
P. Pratheeshkumar, Girija Kuttan, P. Thejass
In Vitro Anti-proliferative Effects on NB4 Human Leukemia Cells and Physicochemical Screening of Pleurotus sp. (Higher Basidiomycetes) Mycelia from Cuba
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 3
Edgar Hernandez, Maria Cristina Tejedor, Ana Isabel Garcia-Perez, Pilar Sancho, Angel Herraez, Humberto J. Morris, Gabriel Llaurado, Jose Carlos Diez, Maria del Carmen Boyano-Adanez
Effects of Birch Polypore Mushroom, Piptoporus betulinus (Agaricomycetes), the "Iceman’s Fungus", on Human Immune Cells
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 12
Ulrike Lindequist, Stefanie Meier, Carsten Gründemann, Carmen Steinborn, Zeyad Alresly, Roman Huber, Franziska Grunewald, Radim Wille
Extrinsic and Intrinsic Apoptotic Responses Induced by Shiitake Culinary-Medicinal Mushroom Lentinus edodes (Agaricomycetes) Aqueous Extract against a Larynx Carcinoma Cell Line
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 1
Sidnei Moura, João Pegas Henriques, Tiane C. Finimundy, Gustavo Scola, Aldo J. P. Dillon, Fernando J. Scariot, Sérgio Echeverrigaray, Mariana Roesch-Ely